Salama Amr, Levin Yana, Jha Pramod, Alweis Richard
Department of Medicine, Unity Hospital, Rochester, NY, USA.
Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
J Community Hosp Intern Med Perspect. 2017 Sep 19;7(4):222-226. doi: 10.1080/20009666.2017.1351290. eCollection 2017 Oct.
Loperamide is an over-the-counter antidiarrheal agent that is considered by many patients to be safe, but has been used as a drug of abuse due to its opioid properties. However, cardiotoxicity has been reported, prompting the FDA to release a warning regarding the arrhythmogenic potential of loperamide. We present a case of a 38-year-old female presenting with cardiac arrest thought to be secondary to abuse of the loperamide that she was using to alleviate the heroin withdrawal symptoms. Cardiac ischemia and other drug toxicities were ruled out. Loperamide induces QTc prolongation and cardiac dysrhythmias. She had recurrent ventricular arrhythmias with multiple cardiac arrests. The persistence of the cardiotoxicity for a longer duration than previously reported in the literature is unique in this clinical presentation. We also highlight the potential mechanisms for loperamide cardiotoxicity and its challenging management. ACLS: Advanced cardiac life support; GI: Gastrointestinal.
洛哌丁胺是一种非处方止泻药,许多患者认为它是安全的,但因其具有阿片类特性而被用作滥用药物。然而,已有心脏毒性的报道,促使美国食品药品监督管理局(FDA)发布了关于洛哌丁胺致心律失常潜力的警告。我们报告一例38岁女性病例,该患者出现心脏骤停,据认为这是由于她滥用洛哌丁胺以缓解海洛因戒断症状所致。排除了心脏缺血和其他药物毒性。洛哌丁胺可导致QTc延长和心脏节律失常。她反复出现室性心律失常并多次心脏骤停。这种心脏毒性持续时间比文献中先前报道的更长,这在该临床表现中是独特的。我们还强调了洛哌丁胺心脏毒性的潜在机制及其具有挑战性的治疗。ACLS:高级心脏生命支持;GI:胃肠道。